Stay updated on Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial page.

Latest updates to the Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial page
- Check5 days agoChange DetectedThe study record now shows termination due to lack of efficacy at the 5 mg dose and includes the Results First Posted date (2021-05-07).SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check34 days agoChange Detected- Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%

- Check41 days agoChange DetectedUpdated version to v3.1.0 and removed several drug-safety topic items (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while retaining an older revision tag v3.0.2 in deletions, indicating a reorganization of content and scope.SummaryDifference0.3%

- Check55 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1); the Back to Top link has been removed.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check69 days agoChange DetectedThe webpage has undergone significant updates, including the addition of specific facility names and locations related to Alzheimer's care, as well as new topics on drug safety and counterfeit drugs. The previous version's details about locations and certain related topics have been removed.SummaryDifference2%

Stay in the know with updates to Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial page.